Skip to main content
. 2022 Jun 3;8(8):847–856. doi: 10.1093/ehjcvp/pvac036

Figure 4.

Figure 4

Therapeutic ranges and remaining plasma concentrations of (A) Apixaban, (B) Rivaroxaban and (C) Ticagrelor over 6 h of haemoperfusion. The grey shaded region represents the therapeutic window for each drug based on its clinical use. DrugSorb-ATR was able to reduce the drug concentration below the trough plasma level within 30–60 minutes for all drugs tested. Results presented as mean ± SD, n = 5.